Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)Annals of Oncology - Tập 31 - Trang 1040-1045 - 2020
M. Montopoli, S. Zumerle, R. Vettor, M. Rugge, M. Zorzi, C.V. Catapano, G.M. Carbone, A. Cavalli, F. Pagano, E. Ragazzi, T. Prayer-Galetti, A. Alimonti
Immune checkpoint inhibitors (ICIs) as “chemotherapy (Ctx) sensitization” strategy in advanced solid tumoursAnnals of Oncology - Tập 30 - Trang v519-v520 - 2019
F J Ros Montana, I. Matos, G. Vilacampa, A. Azaro, J. Martin-Liberal, C. Hierro, I. Brana, C. Viaplana, M Vieito Villar, I. Gardeazabal, C. Saura, L Fariñas Madrid, T Macarulla Mercade, O. Saavedra, N. Pardo, M Ochoa de Olza, E. Muñoz-Couselo, J. Tabernero, R. Dienstmann, E. Garralda
Overall Survival According to Patient Subgroups: Results from a Pooled Analysis of 5 Observational or Phase Iv Studies of Bevacizumab in Metastatic Colorectal CancerAnnals of Oncology - Tập 25 - Trang iv176 - 2014
A. Grothey, D. Arnold, E. Van Cutsem, T. Bekaii-Saab, M. Kozloff, J. Bennouna, C. Revil, M. Donica, N. Sommer, B. Leutgeb, M. Ekstrand-Olsen, F. Hermann, H. Hurwitz
Glycemic index, glycemic load and renal cell carcinoma riskAnnals of Oncology - Tập 20 - Trang 1881-1885 - 2009
C. Galeone, C. Pelucchi, L. Dal Maso, E. Negri, R. Talamini, M. Montella, V. Ramazzotti, R. Bellocco, S. Franceschi, C. La Vecchia
Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patientsAnnals of Oncology - Tập 24 - Trang 1691-1697 - 2013
L. Boussemart, E. Routier, C. Mateus, K. Opletalova, G. Sebille, N. Kamsu-Kom, M. Thomas, S. Vagner, M. Favre, G. Tomasic, J. Wechsler, L. Lacroix, C. Robert